PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule - PubMed (original) (raw)

. 1993 May;142(5):1359-72.

Affiliations

PMID: 7684194
PMCID: PMC1886928

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule

B Falini et al. Am J Pathol. 1993 May.

Abstract

A new anti-macrophage monoclonal antibody (PG-M1) was produced by immunizing BALB/c mice with fresh spleen cells from a patient with Gaucher's disease. PG-M1 reacts strongly with a fixative-resistant epitope of an intracytoplasmic molecule, selectively expressed by virtually all macrophages of the human body. Although attempts to immunoprecipitate the molecule recognized by PG-M1 have failed so far, the reactivity of the antibody with COS-1 and WOP cells transfected with a human complementary DNA clone encoding for the CD68 antigen suggests that PG-M1 is a new member of the CD68 cluster. However, unlike other CD68 antibodies (KP1, EBM11, etc.), which react with both macrophages and myeloid cells, PG-M1 detects a fixative-resistant epitope on the macrophage-restricted form of the CD68 antigen. In 957 routinely fixed, paraffin-embedded samples, PG-M1 showed a more restricted reactivity with elements of the monocyte/macrophage lineage than the previously described monoclonal antibodies MAC-387 (anti-calgranulins), KP1 (CD68) and Ki-M1P. Among hematological malignancies, PG-M1 only labels acute leukemias of M4 and M5 type and rare examples of malignant histiocytosis/true histiocytic sarcoma. In contrast, acute leukemias of the M1, M2, M3, M6, M7, and L1-L3 types, non-Hodgkin's lymphomas, and Hodgkin and Reed-Sternberg cells of Hodgkin's disease are consistently PG-M1-negative. In the daily diagnostic practice, PG-M1 seems to be particularly valuable for the diagnosis of myelomonocytic or monocytic leukemia and neoplasms of true histiocytic origin in routine paraffin sections.

PubMed Disclaimer

Cited by

Age-dependent changes in porcine alveolar macrophage function during the postnatal period of alveolarization.
Dickie R, Tasat DR, Alanis EF, Delfosse V, Tsuda A. Dickie R, et al. Dev Comp Immunol. 2009 Feb;33(2):145-51. doi: 10.1016/j.dci.2008.07.016. Epub 2008 Sep 4. Dev Comp Immunol. 2009. PMID: 18775449 Free PMC article.
Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
Thiele J, Kvasnicka HM, Titius BR, Parpert U, Nebel R, Zankovich R, Dienemann D, Stein H, Diehl V, Fischer R. Thiele J, et al. Ann Hematol. 1993 Jun;66(6):291-302. doi: 10.1007/BF01695971. Ann Hematol. 1993. PMID: 8318559
A new monoclonal antibody (3A5) that recognises a fixative resistant epitope on tissue macrophages and monocytes.
Jaspars EH, Bloemena E, Bonnet P, Scheper RJ, Kaiserling E, Meijer CJ. Jaspars EH, et al. J Clin Pathol. 1994 Mar;47(3):248-52. doi: 10.1136/jcp.47.3.248. J Clin Pathol. 1994. PMID: 7512995 Free PMC article.
Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination.
Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, Condeelis JS, Jones JG. Robinson BD, et al. Clin Cancer Res. 2009 Apr 1;15(7):2433-41. doi: 10.1158/1078-0432.CCR-08-2179. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318480 Free PMC article.
Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer.
Chen XJ, Han LF, Wu XG, Wei WF, Wu LF, Yi HY, Yan RM, Bai XY, Zhong M, Yu YH, Liang L, Wang W. Chen XJ, et al. J Cancer. 2017 Oct 17;8(18):3868-3875. doi: 10.7150/jca.21444. eCollection 2017. J Cancer. 2017. PMID: 29151975 Free PMC article.

References

1. Am J Pathol. 1989 Jan;134(1):187-92 - PubMed
1. Int J Cancer Suppl. 1988;3:45-9 - PubMed
1. J Clin Pathol. 1989 Apr;42(4):414-21 - PubMed
1. Br J Haematol. 1989 Sep;73(1):6-11 - PubMed
1. Br J Haematol. 1989 Oct;73(2):187-98 - PubMed

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule - PubMed (original) (raw)